Russian Contacts Sitemap

For Patients & Their Families For Doctors & Healthcare Professionals For R&D-Center Clients

For Developers & Inventors For Suppliers For Partners

Home R&D-Center About R&D-Center NovaMedica Innotech Conclusion on the Conformity of the Manufacturer of Drug Products for Medical Use with the Good Manufacturing Practices (GMP)

Conclusion on the Conformity of the Manufacturer of Drug Products for Medical Use with the Good Manufacturing Practices (GMP)

Shareholders

Pipeline

Media Center

NovaMedica will produce migraine drug Relonova in Moscow

23 March 2023
A resource for anti-tumor drugs testing has been launched in Russia

23 March 2023
Building a Community of Trust in Epilepsy & Rare Syndromes

23 March 2023
Marinus Pharmaceuticals Receives FDA Orphan Drug Designation for Ganaxolone in the Treatment of Lennox-Gastaut Syndrome

22 March 2023